Skip to results
Modify your search
NARROW
1-10 of 10
Authors: Christoph D Spinner
Journal Article
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review Open Access
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 3, March 2025, Pages 633–644, https://doi.org/10.1093/jac/dkae482
Published: 13 January 2025
Journal Article
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men (PROBE-C Study) Free
Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e607–e612, https://doi.org/10.1093/cid/ciac680
Published: 25 August 2022
Journal Article
Detailed stratified GWAS analysis for severe COVID-19 in four European populations Open Access
Human Molecular Genetics, Volume 31, Issue 23, 1 December 2022, Pages 3945–3966, https://doi.org/10.1093/hmg/ddac158
Published: 15 July 2022
Journal Article
Novel genes and sex differences in COVID-19 severity Open Access
Human Molecular Genetics, Volume 31, Issue 22, 15 November 2022, Pages 3789–3806, https://doi.org/10.1093/hmg/ddac132
Published: 16 June 2022
Journal Article
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254 Open Access
Clinical Infectious Diseases, Volume 75, Issue 5, 1 September 2022, Pages 786–794, https://doi.org/10.1093/cid/ciab1065
Published: 06 January 2022
Journal Article
Reply: Beyond Viral Suppression Open Access
Open Forum Infectious Diseases, Volume 8, Issue 10, October 2021, ofab073, https://doi.org/10.1093/ofid/ofab073
Published: 15 February 2021
Journal Article
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study Open Access
Open Forum Infectious Diseases, Volume 7, Issue 9, September 2020, ofaa356, https://doi.org/10.1093/ofid/ofaa356
Published: 13 August 2020
Journal Article
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study Open Access
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 10, October 2020, Pages 3082–3084, https://doi.org/10.1093/jac/dkaa234
Published: 07 July 2020
Journal Article
541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging Open Access
Open Forum Infectious Diseases, Volume 5, Issue suppl_1, November 2018, Page S201, https://doi.org/10.1093/ofid/ofy210.550
Published: 26 November 2018
Journal Article
Pharmacokinetics of once-daily dolutegravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 9, September 2017, Pages 2679–2681, https://doi.org/10.1093/jac/dkx105
Published: 24 July 2017
